We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Advanced Medical Solutions Group Plc | LSE:AMS | London | Ordinary Share | GB0004536594 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
1.80 | 0.95% | 192.20 | 191.80 | 192.40 | 192.20 | 190.20 | 190.20 | 4,692,768 | 16:35:17 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Plastics,resins,elastomers | 126.21M | 15.89M | 0.0732 | 26.20 | 416.61M |
TIDMAMS
RNS Number : 3093J
Advanced Medical Solutions Grp PLC
27 June 2017
For filings with the FCA include the annex For filings with issuer exclude the annex TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) -------------------------------------------------------------------------------------- 1. Identity of the issuer or the underlying issuer Advanced Medical Solutions of existing shares to which Group plc voting rights are attached: (ii) ------------------------------------------------------ ------------------------------ 2 Reason for the notification (please tick the appropriate box or boxes): -------------------------------------------------------------------------------------- An acquisition or disposal of voting rights ü ------------------------------------------------------- ----------------------------- An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached ------------------------------------------------------- ----------------------------- An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments ------------------------------------------------------- ----------------------------- An event changing the breakdown of voting rights ------------------------------------------------------- ----------------------------- Other (please specify): ----------------------------------------------------- ----------------------------- 3. Full name of person(s) Octopus Investments Nominees subject to the Limited notification obligation: (iii) ------------------------------------------------------ ------------------------------ 4. Full name of shareholder(s) n/a (if different from 3.):(iv) ------------------------------------------------------ ------------------------------ 5. Date of the transaction 23/06/2017 and date on which the threshold is crossed or reached: (v) ------------------------------------------------------ ------------------------------ 6. Date on which issuer notified: 26/06/2017 ------------------------------------------------------ ------------------------------ 7. Threshold(s) that is/are crossed or reached: (vi, vii) 9% ------------------------------------------------------ ------------------------------ 8. Notified details: n/a ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------- A: Voting rights attached to shares (viii, ix) ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Class/type Situation previous Resulting situation after the of to the triggering triggering transaction shares transaction if possible using the ISIN CODE ------------- -------------------------------------------------------------------------- ---------------------------------------------------------------------------------- Number Number Number Number of % of voting of of of shares voting rights (x) Shares Voting rights Rights ------------- ------------------------------------ ------------------------------------ --------------------- -------------------------------- ------------------------- Direct Direct Indirect Direct Indirect (xi) (xii) ------------- -------------------------------- -------------------------------- --------------------- --------------------- --------- ------------ ----------- GB0004536594 19,004,675 19,004,675 19,256,735 19,256,735 9.10% ------------------------------------ ------------------------------------ --------------------- --------------------- --------- ------------ ----------- B: Qualifying Financial Instruments ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Type of Expiration Exercise/ Number of voting % of voting financial date Conversion rights that rights instrument (xiii) Period (xiv) may be acquired if the instrument is exercised/ converted. ----------------- ---------------------------------- ----------------------------------------------------------- ---------------------------------- --------------------- C: Financial Instruments with similar economic effect to Qualifying Financial Instruments (xv, xvi) ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Type of Exercise Expiration Exercise/ Number of voting % of voting financial price date Conversion rights instrument rights (xix, instrument (xvii) period refers to xx) (xviii) --------------- ---------------------------------- ---------------------------------- ----------------------- ---------------------------------- ----------------------- Nominal Delta --------------- ---------------------------------- ---------------------------------- ----------------------- ---------------------------------- ------------ --------- Total (A+B+C) ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Number of voting rights Percentage of voting rights ------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------- 19,256,735 9.10% ------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------- 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: (xxi) ----------------------------------------------------------------------- n/a Proxy Voting: ----------------------------------------------------------------------- 10. Name of the proxy holder: n/a ------------------------------------------------------- -------------- 11. Number of voting rights proxy n/a holder will cease to hold: ------------------------------------------------------- -------------- 12. Date on which proxy holder will n/a
cease to hold voting rights: ------------------------------------------------------- -------------- 13. Additional information: ------------------------------------------------------- -------------- 14. Contact name: Daryl O'Brien ------------------------------------------------------- -------------- 15. Contact telephone number: 0203 1400 942 ------------------------------------------------------- -------------- Note: Annex should only be submitted to the FCA not the issuer Annex: Notification of major interests in share A: Identity of the persons or legal entity subject to the notification obligation ---------------------------------------------------------------- Full name Peter Orsi (including legal form of legal entities) ------------------------------------- ------------------------- Contact address 33 Holborn, London, EC1N (registered office for legal 2HT entities) ------------------------------------- ------------------------- Phone number & email 020 7710 2877 ------------------------------------- ------------------------- Other useful information (at least legal representative for legal persons) ------------------------------------- ------------------------- B: Identity of the notifier, if applicable ---------------------------------------------------------------- Full name ------------------------------------- ------------------------- Contact address ------------------------------------- ------------------------- Phone number & email ------------------------------------- ------------------------- Other useful information (e.g. functional relationship with the person or legal entity subject to the notification obligation) ------------------------------------- ------------------------- C: Additional information ---------------------------------------------------------------- For notes on how to complete form TR-1 please see the FCA website.
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLEAEKXASPXEFF
(END) Dow Jones Newswires
June 27, 2017 07:01 ET (11:01 GMT)
1 Year Advanced Medical Solutions Chart |
1 Month Advanced Medical Solutions Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions